{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:07:17Z","timestamp":1785409637042,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jgar.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T21:46:59Z","timestamp":1500760019000},"page":"75-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Extensively drug-resistant tuberculosis (XDR-TB) in Morocco"],"prefix":"10.1016","volume":"11","author":[{"given":"Wifak","family":"Ennassiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Jaouhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Cherki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Charof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-3389","authenticated-orcid":false,"given":"Abdelkarim","family":"Filali-Maltouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouafae","family":"Lahlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2017.07.002_bib0005","series-title":"Global tuberculosis report","first-page":"2016","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jgar.2017.07.002_bib0010","series-title":"Global tuberculosis report","first-page":"2015","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.jgar.2017.07.002_bib0015","series-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): global report on surveillance and response","first-page":"2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.jgar.2017.07.002_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2017.07.002_bib0025","series-title":"Report of the meeting of the WHO Global Task Force on XDR-TB","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.jgar.2017.07.002_bib0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cegh.2013.02.003","article-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB) management: current issues","volume":"1","author":"Prasad","year":"2013","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.jgar.2017.07.002_bib0035","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.5588\/ijtld.15.0389","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015","volume":"19","author":"Zhang","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2017.07.002_bib0040","first-page":"207","article-title":"Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco","volume":"6","author":"Zakham","year":"2013","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2017.07.002_bib0045","series-title":"Multidrug-resistant tuberculosis (MDR-TB). 2016 update","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jgar.2017.07.002_bib0050","series-title":"The global MDR-TB and XDR-TB response plan 2007\u20132008","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.jgar.2017.07.002_bib0055","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2017.07.002_bib0060","series-title":"Tuberculosis country profiles","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jgar.2017.07.002_bib0065","series-title":"Tuberculosis report 2015","author":"National Tuberculosis Control Program","year":"2015"},{"key":"10.1016\/j.jgar.2017.07.002_bib0070","series-title":"Guidelines for surveillance of drug resistance in tuberculosis","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.jgar.2017.07.002_bib0075","series-title":"The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs. Policy guidance","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jgar.2017.07.002_bib0080","series-title":"Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.jgar.2017.07.002_bib0085","series-title":"Multidrug resistant TB management guidelines","author":"National Tuberculosis Control Program","year":"2011"},{"key":"10.1016\/j.jgar.2017.07.002_bib0090","series-title":"Guidelines for the programmatic management of drug-resistant tuberculosis","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.jgar.2017.07.002_bib0095","first-page":"565","article-title":"Mycobacteria: laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti","year":"1963","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jgar.2017.07.002_bib0100","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jgar.2017.07.002_bib0105","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JCM.00081-09","article-title":"Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin\u2013capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens","volume":"47","author":"Hillemann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2017.07.002_bib0110","first-page":"278","article-title":"Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco","volume":"3","author":"Chaoui","year":"2009","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2017.07.002_bib0115","doi-asserted-by":"crossref","first-page":"e47113","DOI":"10.1371\/journal.pone.0047113","article-title":"The genotypic population structure of Mycobacterium tuberculosis complex from Moroccan patients reveals a predominance of Euro-American lineages","volume":"7","author":"Lahlou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2017.07.002_bib0120","first-page":"392","article-title":"Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study","volume":"130","author":"Sharma","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2017.07.002_bib0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tube.2012.10.007","article-title":"Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal","volume":"93","author":"Poudel","year":"2013","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jgar.2017.07.002_bib0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/23744235.2015.1125999","article-title":"Evaluation of the GenoType\u00ae MTBDRsl assay in Korean patients with MDR or XDR tuberculosis","volume":"48","author":"Jeong","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jgar.2017.07.002_bib0135","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1038\/emi.2014.21","article-title":"Association of gyrA\/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis","volume":"3","author":"Li","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jgar.2017.07.002_bib0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/QCO.0b013e328319bce6","article-title":"Multidrug-resistant and extensively drug resistant tuberculosis: a review","volume":"21","author":"Chan","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jgar.2017.07.002_bib0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clinmicnews.2016.02.004","article-title":"Extensively drug resistant Mycobacterium tuberculosis in Kelantan East Coast of Malaysia: first two cases","volume":"3","author":"Elmi","year":"2016","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.jgar.2017.07.002_bib0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2016.04.026","article-title":"New agents for the treatment of drug resistant Mycobacterium tuberculosis","volume":"102","author":"Hoagland","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jgar.2017.07.002_bib0155","series-title":"WHO treatment guidelines for drug-resistant tuberculosis. 2016 update","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.jgar.2017.07.002_bib0160","series-title":"Frequently asked questions: XDR-TB","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.jgar.2017.07.002_bib0165","series-title":"TB elimination. Extensively drug-resistant tuberculosis (XDR-TB)","author":"US Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.jgar.2017.07.002_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jiph.2011.06.003","article-title":"Extensively drug-resistant tuberculosis case in the Thames Valley, UK and public health interventions","volume":"4","author":"Abid","year":"2011","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jgar.2017.07.002_bib0175","series-title":"What it DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.jgar.2017.07.002_bib0180","series-title":"The end TB strategy","author":"World Health Organization","year":"2016"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651730125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651730125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T21:24:30Z","timestamp":1535577870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651730125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"alternative-id":["S221371651730125X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.07.002","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extensively drug-resistant tuberculosis (XDR-TB) in Morocco","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of International Society for Chemotherapy of Infection and Cancer.","name":"copyright","label":"Copyright"}]}}